Silencing histone deacetylase 2 using small hairpin RNA induces regression of fibrotic plaque in a rat model of Peyronie's disease

Inhibition of histone deacetylase 2 mitigates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque

(2013) Ji-Kan Ryu et al.   ASIAN JOURNAL OF ANDROLOGY

TGF-β signaling in fibrosis

(2011) Anna Biernacka et al.   GROWTH FACTORS

Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins

(2011) Maoyin Pang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Unknown

(2011) Timothy McKinsey   MOLECULAR MEDICINE

Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders

(2010) M. Pang et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Transforming Growth Factor (TGF)-β Type I Receptor Kinase (ALK5) Inhibitor Alleviates Profibrotic TGF-β1 Responses in Fibroblasts Derived from Peyronie's Plaque

(2010) Shuguang Piao et al.   Journal of Sexual Medicine

The Effect of Epigenetic Therapy on Congenital Neurogenic Bladders—A Pilot Study

(2010) Steve J. Hodges et al.   UROLOGY

IN-1130, a Novel Transforming Growth Factor-β Type I Receptor Kinase (Activin Receptor-like Kinase 5) Inhibitor, Promotes Regression of Fibrotic Plaque and Corrects Penile Curvature in a Rat Model of Peyronie's Disease

(2009) Ji-Kan Ryu et al.   Journal of Sexual Medicine